In the September 9 cover article of Cancer Cell, researchers integrated 10x single cell and spatial technologies to identify a mechanism of glioblastoma recurrence in mice and develop a promising ...

PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to ...

New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies With the new assay, researchers can now profile up to 384 samples ...

10x Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now. On October 29, 2025, 10x Genomics announced the launch of its next-generation Chromium Flex assay, designed to help ...

SPT Labtech and 10x Genomics have partnered to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x’s Chromium Single Cell platform ...

After growing its Xenium In Situ single-cell spatial imaging platform into its third successful technology family last year, 10x Genomics has no plans for launching a fourth platform in 2024—but will ...

New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology "The new products we have planned for 2024 will take 10x to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible ...